180 Life Sciences Corp (ATNF): right

Reply Private New

Replies (3) Next 10 Prev Next

Send PM Follow Ignore

Followers	654
Posts	83438
Boards Moderated	0
Alias Born	05/25/2008

The Night Stalker

Re: tw0122 post# 132

Friday, 05/19/2023 4:32:21 PM

Friday, May 19, 2023 4:32:21 PM

right

Keep Last Read

Replies (3) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ATNF News

180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 03/14/2024 12:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 11:03:16 AM
Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:49:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 01:00:09 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/28/2024 11:42:18 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/28/2024 11:39:40 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/28/2024 11:37:05 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 11:30:47 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:00:18 PM
180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan • GlobeNewswire Inc. • 02/26/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 01:01:20 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/16/2024 10:10:53 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/16/2024 10:08:00 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/16/2024 10:05:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:15:23 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/12/2024 09:15:26 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/31/2024 10:29:48 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:00:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 01:30:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 01:30:22 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 11:42:49 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/27/2023 09:15:23 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/26/2023 09:15:04 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 10:00:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 01:00:26 PM

More ATNF News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover